Reply to O. Sütcüoğlu et al, F. Negri et al, and B.C. Yüksel-Reference-Cited by-同舟云学术

Reply to O. Sütcüoğlu et al, F. Negri et al, and B.C. Yüksel

Published:2022-12-01 Issue:34 Volume:40 Page:4029-4031
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Tang Yuan¹^ORCID,Zhou Hai-Tao¹,Li Ye-Xiong¹^ORCID,Jin Jing¹^ORCID

Affiliation:

1. Yuan Tang, MD, State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China; Hai-Tao Zhou, MD, State Key Laboratory of Molecular Oncology and Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, CAMS and PUMC, Beijing, China; Ye-Xiong Li,...

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.22.01225

Reference13 articles.

1. Could the STELLAR Study Change the Rectal Cancer Treatment Algorithm?

2. Unconsolidated Results of Consolidation Chemotherapy Following Short-Course Radiotherapy in Locally Advanced Rectal Cancer

3. Chemoradiotherapy in Locally Advanced Rectal Cancer: Surgeon Perspective

4. Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR)

5. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial